мȸ ǥ ʷ


Warning: getimagesize(/home/virtual/circulationadmin/renewal/econgress/conference/abstract/img_files/fig_550798.jpg) [function.getimagesize]: failed to open stream: No such file or directory in /home/virtual/circulationadmin/new/econgress/conference/manage/schedule/view_abstract.php on line 164
ǥ : ǥ ȣ - 550798   249 
FDG carotid PET/CT can depict the inflammation on echolucent carotid plaque
가톨릭 의과대학 순환기 내과¹,핵의학과 ²
최윤석 ¹ , 윤호중 ¹,윤정숙 ¹, 정우백 ¹,박철수 ¹,이만영 ¹,정욱성 ¹,승기배 ¹,정용안 ²
Objectives: To elucidate the relation between the echolucent plaque on carotid ultrasound and acute inflammation on F-18 FDG carotid PET/CT Methods: Thirty two patients (M:F ratio =19:13, mean age=62 ± 13 years) who underwent carotid ultrasound were divided into two groups—echolucent plaque (n=22), calcified (n=10). All of the patients underwent F-18 FDG carotid PET/CT. The mean standardized uptake values (SUV), namely target to background ratio (TBR) on 180 min delayed F-18 FDG carotid PET/CT images were compared with serum level of secretory phospholipase A2(sPLA2, Cayman Chemical co., Ann Arbor, MI, USA) in terms of the presence of carotid plaque on carotid US. Results: 180 min TBR of carotid arterial wall at echolucent plaque, calcified plaque were 1.40±0.05, 1.23±0.03 in both carotid artery. TBR of carotid arterial walls for echolucent plaque were significantly larger than TBR for calcified plaque at the both side of carotid artery (p<0.05)(Fig). sPLA2 levels in echolucent was larger than in calcified plaque but did not reach the statistical significance.(1.12±1.29 vs 1.04±1.32 ng/ml, p=0.07) Conclusions: Our results show that F-18 FDG carotid PET/CT can depict metabolically active echolucent carotid plaques. Furthermore secretory phospholipase A2 need to be inverstigated for surrogates of atherosclerotic plaque
̹ 󼼺


[ư]


logo 학술대회일정 사전등록안내 초록등록안내 초록등록/관리 숙박 안내 교통 안내 전시 및 광고